JJ
Jones James Director
Board M
US US · SEC (Form 4)
€1,422
▲ Purchases (15 ops.)
Discover the full record of transactions filed by Jones James, Director. Director active across 1 companies, notably Cumberland Pharmaceuticals INC. In total, 18 reports have been published. Total volume traded: €1k. The latest transaction was filed on 1 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 18 total
€73 38 shares @ €1.9241 0.0001% mcap 0.8% of flow
Common Stock
SEC:0001209191-22-040104:0 · 1 Jun 2022
Ideal exit: 26 Feb 2023 (T+270) €70 30 shares @ €2.3313 0.0001% mcap 0.8% of flow
Common Stock
SEC:0001209191-22-036001:0 · 2 May 2022
Ideal exit: 27 Jan 2023 (T+270) €70 28 shares @ €2.5044 0.0001% mcap 0.8% of flow
Common Stock
SEC:0001209191-22-027649:0 · 14 Apr 2022
Ideal exit: 9 Jan 2023 (T+270) €2,361 1,000 shares @ €2.3611 0.0029% mcap 25.7% of flow
Common Stock
SEC:0001209191-22-026146:0 · 16 Mar 2022
€77 21 shares @ €3.6539 0.0001% mcap 2.3% of flow
Common Stock
SEC:0001209191-22-002468 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) €77 21 shares @ €3.6539 0.0001% mcap 0.8% of flow
Common Stock
SEC:0001209191-22-002468:0 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) €97 42 shares @ €2.3104 0.0001% mcap 2.9% of flow
Common Stock
SEC:0001209191-21-067893 · 1 Nov 2021
Ideal exit: 29 Jul 2022 (T+270) €97 42 shares @ €2.3104 0.0001% mcap 1.1% of flow
Common Stock
SEC:0001209191-21-067893:0 · 1 Nov 2021
Ideal exit: 29 Jul 2022 (T+270) €98 42 shares @ €2.3241 0.0001% mcap 2.9% of flow
Common Stock
SEC:0001209191-21-063228 · 1 Oct 2021
Ideal exit: 28 Jun 2022 (T+270) €98 42 shares @ €2.3241 0.0001% mcap 1.1% of flow
Common Stock
SEC:0001209191-21-063228:0 · 1 Oct 2021
Ideal exit: 28 Jun 2022 (T+270) €102 42 shares @ €2.4322 0.0001% mcap 3.1% of flow
Common Stock
SEC:0001209191-21-058527 · 1 Sept 2021
Ideal exit: 29 May 2022 (T+270) €102 42 shares @ €2.4322 0.0001% mcap 1.1% of flow
Common Stock
SEC:0001209191-21-058527:0 · 1 Sept 2021
Ideal exit: 29 May 2022 (T+270) €118 42 shares @ €2.8127 0.0001% mcap 3.6% of flow
Common Stock
SEC:0001209191-21-055483 · 2 Aug 2021
Ideal exit: 29 Apr 2022 (T+270) €118 42 shares @ €2.8127 0.0001% mcap 1.3% of flow
Common Stock
SEC:0001209191-21-055483:0 · 2 Aug 2021
Ideal exit: 29 Apr 2022 (T+270) €113 42 shares @ €2.684 0.0001% mcap 3.4% of flow
Common Stock
SEC:0001209191-21-051438 · 8 Jul 2021
Ideal exit: 4 Apr 2022 (T+270) €113 42 shares @ €2.684 0.0001% mcap 1.2% of flow
Common Stock
SEC:0001209191-21-051438:0 · 8 Jul 2021
Ideal exit: 4 Apr 2022 (T+270) €2,706 1,000 shares @ €2.7055 0.0033% mcap 81.7% of flow
Common Stock
SEC:0001209191-21-039936 · 17 Mar 2021
€2,706 1,000 shares @ €2.7055 0.0033% mcap 29.4% of flow
Common Stock
SEC:0001209191-21-039936:0 · 17 Mar 2021
About Jones James James Jones is an executive at CUMBERLAND PHARMACEUTICALS INC.